These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17210764)

  • 1. High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
    Wolter N; Smith AM; Low DE; Klugman KP
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1092-5. PubMed ID: 17210764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first telithromycin-resistant Streptococcus pneumoniae isolate in Japan associated with erm(B) and mutations in 23S rRNA and riboprotein L4.
    Hirakata Y; Mizuta Y; Wada A; Kondoh A; Kurihara S; Izumikawa K; Seki M; Yanagihara K; Miyazaki Y; Tomono K; Kohno S
    Jpn J Infect Dis; 2007 Feb; 60(1):48-50. PubMed ID: 17314426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe.
    Al-Lahham A; Appelbaum PC; van der Linden M; Reinert RR
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3897-900. PubMed ID: 17065627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F; Willcock J; Amyes S
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation.
    Wolter N; Smith AM; Farrell DJ; Northwood JB; Douthwaite S; Klugman KP
    Antimicrob Agents Chemother; 2008 Feb; 52(2):435-40. PubMed ID: 18056269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of resistance to telithromycin in Streptococcus pneumoniae.
    Hisanaga T; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2005 Sep; 56(3):447-50. PubMed ID: 16006449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3.
    Jenkins SG; Farrell DJ; Patel M; Lavin BS
    J Infect; 2005 Dec; 51(5):355-63. PubMed ID: 15950288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
    Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
    Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.
    Reinert RR; van der Linden M; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3520-2. PubMed ID: 16048973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin.
    Kresken M; Henrichfreise B; Bagel S; Brauers J; Wiedemann B
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3193-5. PubMed ID: 15273149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations.
    Zhanel GG; Johanson C; Hisanaga T; Mendoza C; Laing N; Noreddin A; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2004 Dec; 54(6):1072-7. PubMed ID: 15531596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-kill kinetics of Streptococcus pneumoniae with reduced susceptibility to telithromycin.
    Al-Lahham A; Reinert RR
    Chemotherapy; 2007; 53(3):190-3. PubMed ID: 17347565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003.
    Farrell DJ; Felmingham D
    Antimicrob Agents Chemother; 2004 May; 48(5):1882-4. PubMed ID: 15105150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.
    Kim NJ; Park SJ; Choi SH; Lee MS; Choo EJ; Kwak YG; Woo JH; Ryu J; Jeong JY; Kim YS
    Microb Drug Resist; 2005; 11(3):260-5. PubMed ID: 16201929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
    Jenkins SG; Brown SD; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of reduced telithromycin susceptibility of Streptococcus pneumoniae isolated clinically in Japan.
    Takaya A; Kitagawa N; Kuroe Y; Endo K; Okazaki M; Yokoyama E; Wada A; Yamamoto T
    FEMS Microbiol Lett; 2010 Jun; 307(1):87-93. PubMed ID: 20402783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.
    Hoban DJ; Wierzbowski AK; Nichol K; Zhanel GG
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2147-50. PubMed ID: 11408241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.